Skip to main content
Log in

Autoimmune disease

Treatment of SLE with anti-CD19 CAR-T cells

  • Research Highlight
  • Published:

From Nature Reviews Nephrology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

Original article

  • Mackensen, A. et al. Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. Nat. Med. 28, 2124–2132 (2022)

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ellen F. Carney.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carney, E.F. Treatment of SLE with anti-CD19 CAR-T cells. Nat Rev Nephrol 18, 743 (2022). https://doi.org/10.1038/s41581-022-00651-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41581-022-00651-3

  • Springer Nature Limited

Navigation